Paul Tudor Jones's RCKT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 50,493 shares of Rocket Pharmaceuticals, Inc. (RCKT) worth $180,765, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in RCKT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 22,873 shares. Largest reduction occurred in Q2 2022, reducing 32,787 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Rocket Pharmaceuticals (RCKT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rocket Pharmaceuticals (RCKT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +8,082 | Add 19.06% | 50,493 | $3.58 |
| Q4 2025 | -7,696 | Reduce 15.36% | 42,411 | $3.51 |
| Q3 2025 | -66 | Reduce 0.13% | 50,107 | $3.26 |
| Q2 2025 | +36 | Add 0.07% | 50,173 | $2.45 |
| Q1 2025 | +19,012 | Add 61.08% | 50,137 | $6.67 |
| Q4 2024 | +14,338 | Add 85.41% | 31,125 | $12.57 |
| Q3 2024 | +16,787 | New Buy | 16,787 | $18.47 |
| Q3 2023 | -22,873 | Sold Out | 0 | $0.00 |
| Q2 2023 | +22,873 | New Buy | 22,873 | $19.87 |
| Q2 2022 | -32,787 | Sold Out | 0 | $0.00 |
| Q1 2022 | +32,787 | New Buy | 32,787 | $15.86 |
Paul Tudor Jones's Rocket Pharmaceuticals Investment FAQs
Paul Tudor Jones first purchased Rocket Pharmaceuticals, Inc. (RCKT) in Q1 2022, acquiring 32,787 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Rocket Pharmaceuticals, Inc. (RCKT) for 11 quarters since Q1 2022.
Paul Tudor Jones's largest addition to Rocket Pharmaceuticals, Inc. (RCKT) was in Q1 2022, adding 32,787 shares worth $520,000.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 50,493 shares of Rocket Pharmaceuticals, Inc. (RCKT), valued at approximately $180,765.
As of the Q1 2026 filing, Rocket Pharmaceuticals, Inc. (RCKT) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Rocket Pharmaceuticals, Inc. (RCKT) was 50,493 shares, as reported at the end of Q1 2026.